Toggle navigation
Works
People
Organizations
Repositories
Pages
About
Statistics
Support
Sign In
Loading...
Loading...
Collaborative development with exclusive patent, know-how and process license to use the 'Sativex,' 'Nabidiolex' and 'Tetranabinex' trademarks and trade names to develop, make, have made, use, sell, offer, import, exploit and sublicense a pharmaceutical product that is an oromucosal spray containing tetrahydrocannabinol from 'Tetrabinex' and Cannabis sativa, and cannabidiol, including its formulation improvements, and other products containing a certain ratio of CBD and THC drug substances, to treat, diagnose, prevent and palliate advanced and early stage cancer pain, neuropathic and other pain, and other diseases, conditions, syndromes and maladies in humans and animals, including multiple sclerosis, with licensor to supply products.
https://doi.org/10.34675/l36873
Loading...
Download Metadata
Cite as
APA
Harvard
MLA
Vancouver
Chicago
IEEE
Download Reports
Related Works (CSV)
Share
Email
Twitter
Facebook
Creators
Registration
RoyaltyStat
DOI registered
August 5, 2019
via DataCite
Content published 2013 in
RoyaltyStat Library
Text